Chris Watson

EVP, Executive Creative Director

Chris has 25+ years experience in the advertising industry, half of which were spent in general advertising working on dot coms, cable networks, consumer electronics, financial services, fast food, and packaged goods.

He got his start in the world of pharmaceutical advertising at CDM, working on Amgen and Pfizer accounts such as Aranesp, Caduet, Diflucan, Lipitor, Sensipar, and Neurontin.

Before arriving at Sentrix, Chris was Executive Creative Director at Harrison and Star, where he oversaw strategic and creative output for the agency’s oncology portfolio, which included launch and pre-launch activities for a number of brands including Avastin, Cesamet, Erivedge, Gazyva, Genentech BioOncology (Access Solutions, franchise & pipeline communications), Jakafi, Kadcyla, Perjeta, Rituxan, and Zelboraf.

Other notable accounts included Activase, Bayer Aspirin, Cathflo, Citracal, Celgene’s Inflammation & Immunology franchise, Copaxone, Eucerin, Flintstones, Humira, Kaletra, Kogenate, Lucentis, and Pegasys.

Since arriving at Sentrix, Chris has overseen creative output for Lilly’s Baricitinib, Bethkis, Combivent Respimat, Gevokizumab, Heplisav-B, Listerine, Pfizer’s HemeOncology franchise (Bosulif, Besponsa, Mylotarg), Soliris, Taiho Oncology, and ViiV Healthcare.